Smartleaf Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.61K Hold
147
﹤0.01% 2567
2026
Q1
$7.42K Sell
147
-302
-67% -$21.1K ﹤0.01% 2463
2025
Q4
$41.6K Buy
449
+205
+84% +$19.6K ﹤0.01% 1643
2025
Q3
$18.4K Sell
244
-22
-8% -$2.23K ﹤0.01% 1843
2025
Q2
$35.2K Sell
266
-188
-41% -$27.3K ﹤0.01% 1311
2025
Q1
$71.4K Buy
454
+97
+27% +$17.5K 0.01% 985
2024
Q4
$65.9K Buy
357
+229
+179% +$44.5K 0.01% 1043
2024
Q3
$25.9K Buy
128
+37
+41% +$6.43K ﹤0.01% 1202
2024
Q2
$12.3K Buy
91
+25
+38% +$4.73K ﹤0.01% 1301
2024
Q1
$14.1K Buy
66
+5
+8% +$980 ﹤0.01% 922
2023
Q4
$12.4K Buy
+61
New +$9.88K ﹤0.01% 736

Other funds holding INSP

Smartleaf Asset Management's INSP Position: Q2 2026 in Review

Smartleaf Asset Management held its Inspire Medical Systems (INSP) position steady in Q2 2026 at 147 shares worth $6.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

Smartleaf Asset Management first reported a position in INSP in Q4 2023 and has held it in 11 quarters since. The position peaked at $71.4K in Q1 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Smartleaf Asset Management held 147 shares of Inspire Medical Systems worth $6.61K as of Q2 2026.
  • Smartleaf Asset Management left its Inspire Medical Systems share count unchanged in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2567 holding.
  • Smartleaf Asset Management first reported a position in Inspire Medical Systems in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Inspire Medical Systems position peaked at $71.4K in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.